Clinical trial
Effect of Abemaciclib on Metformin Pharmacokinetics and Iohexol Clearance
NCT02884089 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Abemaciclib on Metformin Pharmacokinetics and Iohexol Clearance
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- December 31, 2016
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy